This is a market research request to identify contractors capable of providing contingency compounding and delivery of antineoplastic hazardous drugs for the VA Southern Nevada Health Care System. The potential future requirement is contemplated as a five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract starting October 1, 2026, with services to be performed in Southern Nevada. This notice is for planning purposes only and is not a formal solicitation or a commitment to issue one. Responses are voluntary and will be used to develop the acquisition strategy, including determining set-aside possibilities. Interested parties must submit a statement of interest and capabilities via email by 11:00 AM Pacific Time on March 19, 2026.